CanSinoBIO’s Convidecia effective as booster against Omicron
March 14, 2022Sales and Marketing
According to an academic paper on the efficacy of CanSinoBIO’s recombinant COVID-19 vaccine, published on medRxiv, the vaccine is effective …
UK Health Secretary: rise in COVID-19 cases ‘expected’
March 14, 2022Sales and Marketing
A surge in COVID-19 cases was to be “expected”, following the ease of pandemic restrictions in England, insisted UK Health …
First and only approved medicine in US targeting BRCA mutations in early breast cancer
March 14, 2022Sales and Marketing
LYNPARZA® (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-negative high-risk …
Faron identifies gene mutation to better outcomes for ARDS patients
March 14, 2022Faron Pharmaceuticals has announced the publication of research identifying a novel disease association between a single nucleotide polymorphism (SNP) in …
Valneva provides regulatory update on COVID-19 vaccine candidate
March 11, 2022Medical Communications
Valneva has announced an update on the regulatory review of its inactivated COVID-19 vaccine candidate VLA2001, by the CHMP.The company …
Asia’s COVID-19 deaths surpass one million
March 11, 2022Medical Communications
A Reuters tally has revealed that Asia passed the milestone of one million coronavirus-linked deaths on Friday 11 March. A …
WHO advises Ukraine to destroy disease-causing pathogens in labs
March 11, 2022Medical Communications
WHO has advised Ukraine to destroy “disease-causing pathogens” kept in public health labs, to prevent “any potential spills”, Reuters has …
NIHR unites with health and social care leaders to improve public research involvement
March 11, 2022Medical Communications
The National Institute for Health Research (NIHR) has announced a new shared commitment to improve public health in research. The …
Domain Therapeutics and Explicyte enter immuno-oncology partnership
March 10, 2022Business Services
Domain Therapeutics and Explicyte have announced the signing of a partnership agreement. The two companies aim to combine their expertise …
AI drug discovery collaboration for rare disease cystinosis
March 10, 2022Business Services
Insilico Medicine has entered a research and development collaboration with the Mechanisms of Inherited Kidney Disorders (MIKADO) group at the …
$31 million to progress pipeline of genetic modifiers in cancer and rare diseases
March 10, 2022Business Services
Scenic Biotech has announced a Series A financing of roughly $31 million, supporting the creation of new programmes based on …
MHRA approves Phase I/II clinical trial of IN3BIO vaccine for colorectal cancer patients
March 10, 2022Business Services
The MHRA has approved a Phase I/II clinical trial of IN3BIO’s colorectal cancer vaccine. This is the company’s second global …
Vicore adds to rare lung disease pipeline with PAH indication
March 9, 2022Research and Development
Vicore Pharma has announced plans to initiate a clinical trial with C21 in pulmonary arterial hypertension (PAH).
NICE draft guidance does not recommend pembrolizumab plus chemo for triple negative breast cancer
March 9, 2022Research and Development
Draft guidance published by NICE for public consultation does not recommend pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) for …
Omicron sub-variant BA.2 makes up 11.6% of COVID-19 variants in US
March 9, 2022Research and Development
The CDC said that the BA.2 sub-variant of Omicron is estimated to be 11.6% of the coronavirus variants circulating in …
MHRA authorisation of new treatment for chronic kidney disease associated with diabetes
March 9, 2022Research and Development
The MHRA has authorised the use of Kerendia® (finerenone) (10mg or 20mg), an oral, first-in-class non-steroidal, selective mineralocorticoid receptor (MR) …
Moderna announces its global public health strategy
March 8, 2022Moderna has announced its global public health strategy through four new initiatives which aim to advance mRNA vaccines for the …
Study may see end of need for invasive endometriosis diagnosis surgery
March 8, 2022Manufacturing and Production
A new study of women living with endometriosis is underway, exploring the potential of Artificial intelligence (AI), and cutting-edge medical …
Neuraxpharm expands in Southeast Europe
March 8, 2022Manufacturing and Production
Neuraxpharm Group have announced the expansion of its business in Southeast Europe, through the acquisition of Brain Therapeutics, a company …
Major US study finds COVID-19 vaccines not linked to deaths
March 8, 2022Manufacturing and Production
A study into vaccine side-effects, based in the US, has found no link between two COVID-19 jabs and the number …
Latest content
